Literature DB >> 9850927

Risk factors for Alzheimer's disease during aging. Impacts of glucose/energy metabolism.

S Hoyer1.   

Abstract

The majority of Alzheimer patients is of late onset and with unknown etiology. However, several risk factors have been discussed among which age is a most important one with respect to sporadic Alzheimer type dementia (SDAT). Age includes changes in brain glucose/energy metabolism, in both insulin and acetylcholine signal transduction and in membrane function to name the functionally most important ones. Variations in these parameters can form the basis for ongoing changes in terms of the principle of self-organized critically inducing catastrophic i.e. disease processes. Subsequent abnormalities at the cellular and molecular levels may develop including the formation of both amyloid plaques and neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850927     DOI: 10.1007/978-3-7091-7508-8_18

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  15 in total

1.  Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.

Authors:  Marzia Perluigi; Rukhsana Sultana; Giovanna Cenini; Fabio Di Domenico; Maurizio Memo; William M Pierce; Raffaella Coccia; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2009-06-01       Impact factor: 3.494

Review 2.  Indices of metabolic dysfunction and oxidative stress.

Authors:  Gemma Casadesus; Paula I Moreira; Akihiko Nunomura; Sandra L Siedlak; William Bligh-Glover; Elizabeth Balraj; Grace Petot; Mark A Smith; George Perry
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 3.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

Review 4.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

5.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

6.  Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model.

Authors:  Sebastian Jimenez; Manuel Torres; Marisa Vizuete; Raquel Sanchez-Varo; Elisabeth Sanchez-Mejias; Laura Trujillo-Estrada; Irene Carmona-Cuenca; Cristina Caballero; Diego Ruano; Antonia Gutierrez; Javier Vitorica
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

Review 7.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

8.  AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation.

Authors:  Win D Cheung; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

9.  Aniracetam restores the effects of amyloid-beta protein or ageing on membrane fluidity and intracellular calcium concentration in mice synaptosomes.

Authors:  Y Li; J-J Wang; J-X Cai
Journal:  J Neural Transm (Vienna)       Date:  2007-06-08       Impact factor: 3.575

10.  Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons.

Authors:  Sachin Patil; Joseph Melrose; Christina Chan
Journal:  Eur J Neurosci       Date:  2007-10-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.